Company Filing History:
1 out of 832,891 Years Active: 2002
Title: The Innovations of M Alan Permutt in Biotechnology
Introduction
M Alan Permutt, hailing from St. Louis, MO, has made significant contributions to the field of biotechnology through his innovative research and development of human polypeptides. With a focus on human Nkx-6.1 polypeptides, he has paved the way for potential advancements in medical science.
Latest Patents
M Alan Permutt holds one patent titled "Human NKX-6.1 polypeptide-encoding nucleotide sequences." This invention encapsulates a human Nkx-6.1 polypeptide and the nucleotide sequences that encode it. Notably, it includes the polynucleotide sequence of SEQ ID NO:1, along with sequences that can hybridize under stringent conditions to this sequence. Additionally, the invention comprises expression vectors and host cells that include polynucleotides encoding the human Nkx-6.1 polypeptide. Furthermore, it encompasses antibodies that specifically bind to the polypeptide and methods for their production.
Career Highlights
Throughout his career, M Alan Permutt has dedicated himself to pioneering research in the biotechnology sector. His focus on the Nkx-6.1 polypeptide places him at the forefront of investigations that could lead to breakthroughs in therapeutic applications.
Collaborations
M Alan Permutt has collaborated with esteemed colleagues, including Michael S German and Hiroshi Inoue. These partnerships signify his commitment to working within a collaborative environment, enhancing the scope and impact of his research endeavors.
Conclusion
M Alan Permutt's contributions to the field of biotechnology, particularly through his patent on human Nkx-6.1 polypeptides, underscore his role as an innovative inventor. His work not only reflects his scientific acumen but also has the potential to influence future developments in medical science.